All studies
involving human subjects that are conducted in the GCRC must be approved
by an Institutional Review Board (IRB) and the GCRC Advisory Committee (GAC) before initiation of the
study. Institutional
Review Board. The University
of Iowa Institutional Review Board (IRB) for the Colleges of Medicine,
Nursing, Pharmacy, Dentistry, and Public Health is known as IRB-01.Charged
with protection of human subjects participating in research projects, this
committee meets weekly to review the 700 new research projects a year and
the 2500 continuing projects submitted annually. Studies that are
industry-initiated and industry-sponsored are sent to a commercial
IRB, the Western Institutional Review Board (WIRB) for review.
Additional committees may need to review the study protocol. The Human Subjects Office will forward the study protocol to the first two committees listed below; the investigator must send materials directly to the Nursing Research Committee.
GCRC Advisory Committee (GAC). All
studies conducted in the GCRC must also be approved by the GCRC
Advisory Committee (GAC). A member of the GCRC Advisory
Committee reviews the protocol for scientific merit, safety, and
utilization of GCRC resources. If the investigator does not have
peer-reviewed funding then an outside reviewer with expertise in the area
of investigation will also review the protocol. The full GAC
committee then meets monthly to hear the reviews and approve protocols.
|
